By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

GenSpera 

9901 IH 10 West
Suite 800
San Antonio  Texas  78230  U.S.A.
Phone: 210-477-8537 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
GenSpera Announces US Patent For Methods And Compositions For The Detection, Imaging And Treatment Of Cancer 7/30/2014 8:24:02 AM
Media Advisory: GenSpera's G-202 HCC Clinical Trial Presentation From 5th Asia-Pacific Primary Liver Cancer Expert (APPLE) Meeting Available 7/22/2014 1:29:19 PM
GenSpera Presents G-202 HCC Clinical Trial Update At 5th Asia-Pacific Primary Liver Cancer Expert Meeting 7/15/2014 9:12:27 AM
Kareg Corporation Initiates Coverage On GenSpera With A Speculative Buy Recommendation 7/14/2014 11:05:08 AM
GenSpera Release: Kareg Corporation Initiates Coverage On Genspera With A Speculative Buy Recommendation 7/14/2014 9:37:46 AM
GenSpera To Present Ongoing HCC Trial Data At APPLE 2014 Congress July 12th In Taipei 7/7/2014 9:14:52 AM
GenSpera 2014 Biotechnology Industry Organization (BIO) International Presentation Available 6/30/2014 9:59:48 AM
GenSpera Releases 2014 Biotechnology Industry Organization (BIO) International Presentation And HCC Clinical Trial Update For G-202 6/25/2014 6:17:37 AM
GenSpera (GNSZ) Releases Updated Corporate Video: "Genspera Has Targeted Its Active Ingredient Thapsigargin To Kill Only The Cells We Select: Cancer" 6/23/2014 8:06:28 AM
GenSpera CEO, Craig Dionne, To Present Update On Lead Drug Candidate G-202 At 2014 Biotechnology Industry Organization (BIO) International Convention 6/19/2014 6:53:59 AM
12345
//-->